# The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals

> **NCT06404203** · NA · COMPLETED · sponsor: **Medipol University** · enrollment: 120 (actual)

## Conditions studied

- Cognitive Change
- Cytokine Levels
- Neuroinflammation

## Interventions

- **DIETARY_SUPPLEMENT:** Balparmak Apitera Royal Jelly Herbal Capsule Food Supplement 500 mg/day
- **DIETARY_SUPPLEMENT:** Balparmak Apitera Royal Jelly Herbal Capsule Food Supplement 1000 mg/day
- **DIETARY_SUPPLEMENT:** Balparmak Apitera Royal Jelly Herbal Capsule Food Supplement 1500 mg/day
- **OTHER:** Plasebo

## Key facts

- **NCT ID:** NCT06404203
- **Lead sponsor:** Medipol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2026-01-10
- **Final completion:** 2026-01-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404203, "The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06404203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*